COMMUNIQUÉS West-GlobeNewswire

Canada House’s Abba Medix Corp. announces the launch of www.abbamedixgenetics.com to support seed sales to Canadian LPs
17/10/2018
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Oct. 17, 2018 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc (“Canada House” or the “Company”) (CSE: CHV) is proud to [...]
Adverum Biotechnologies Announces Data Presented at the European Society of Gene and Cell Therapy (ESGCT)
17/10/2018
A single intravitreal injection of ADVM-022 in non-human primates (NHP) demonstrated durable expression of aflibercept sustained out to 22 months In an NHP model, ADVM-022 provided ocular expression of aflibercept at [...]
Rexahn Announces $7.5 Million Registered Direct Offering
17/10/2018
ROCKVILLE, Md., Oct. 17, 2018 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American: RNN) today announced it has entered into definitive agreements with institutional investors to purchase approximately 5.77 [...]
Teligent, Inc. Announces FDA Approval of Fluocinonide Cream USP, 0.05%
17/10/2018
BUENA, N.J., Oct. 17, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s abbreviated new drug [...]
Collegium to Host Conference Call to Discuss Third Quarter 2018 Financial Results and Provide Corporate Update
17/10/2018
STOUGHTON, Mass., Oct. 17, 2018 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) announced today that the Company will host a conference call and live audio webcast on Thursday, November 8, 2018 at 4:30 [...]
Albireo Granted Orphan Drug Designation For Lead Product Candidate A4250 for Treatment of Alagille Syndrome
17/10/2018
BOSTON, Oct. 17, 2018 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced the U.S. Food and Drug [...]
Agritek Holdings, Inc. Announces Recreational Cannabis Now Legal in Canada as Company Opens First Hospitality and Leisure Resort Catering to Country
17/10/2018
LOS ANGELES, CA, Oct. 17, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Agritek Holdings, Inc. (OTCQB: AGTK) www.AgritekHoldings.com , a fully integrated, active real estate investor for the cannabis sector in the United [...]
Study Reveals Traditional Digital Advertising Rules Don’t Apply in Clinical Trial Recruitment
17/10/2018
Original Research to Be Presented at Digital Pharma East RALEIGH, N.C., Oct. 17, 2018 (GLOBE NEWSWIRE) -- Syneos Health TM (NASDAQ:SYNH), the only fully integrated biopharmaceutical solutions organization, today [...]
Albireo Receives FDA Fast Track Designation for A4250
17/10/2018
BOSTON, Oct. 17, 2018 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced the U.S. Food and Drug [...]
MedTainer Capturing Larger Share of Canadian Cannabis Market
17/10/2018
CORONA, Calif., Oct. 17, 2018 (GLOBE NEWSWIRE) -- MedTainer™ Inc. ( MDTR-OTCMARKETS ) announced today that they are capturing a larger-than-expected share of the Canadian cannabis packaging market. In the course of the [...]
Onconova Therapeutics Announces Issuance of a New U.S. Patent for Rigosertib
17/10/2018
Granted claims cover both oral and injectable formulations of Rigosertib Newly issued US patent 10,098,862 extends protection for Rigosertib into 2037 Equivalent coverage is being sought worldwide and, if granted, will [...]
Todos Medical, Ltd. Announces Additional Patent Issuance Covering the Use of IR Spectrum of Blood Plasma For Indicating the Presence of Breast Cancer
17/10/2018
REHOVOT, Israel, Oct. 17, 2018 (GLOBE NEWSWIRE) -- Todos Medical, Ltd. Inc. (OTCQB: TOMDF), a clinical-stage in-vitro diagnostics company focused on the development of blood tests for the early detection of cancer, [...]
BrainStorm to Announce Third Quarter Financial Results and Provide Corporate Update on Monday, October 29
17/10/2018
Conference Call and Live Webcast at 8:30am Eastern Time NEW YORK and PETACH TIKVAH, Israel, Oct. 17, 2018 (GLOBE NEWSWIRE) -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell [...]
Nutritional High and Aura Health Announce Partnership to Develop International Markets
17/10/2018
TORONTO, Oct. 17, 2018 (GLOBE NEWSWIRE) -- Nutritional High International Inc. (" Nutritional High ") (CSE: EAT, OTCQB: SPLIF, FRANKFURT:2NU) and Aura Health Inc. (“ Aura ”) ( CSE: BUZZ ) are pleased to announce the [...]
New Jersey Dentist Opens New Office Location in Green Brook
17/10/2018
Dr. John D. Beckwith has expanded his private practice, Cornerstone Dental, with a second office location in Green Brook, New Jersey. HILLSBOROUGH, N.J., Oct. 17, 2018 (GLOBE NEWSWIRE) -- Cornerstone Dental is an all- [...]
Achaogen Submits Marketing Authorization Application to the European Medicines Agency for Plazomicin
17/10/2018
-- MAA submission for complicated urinary tract infections (cUTI), bloodstream infections, and infections due to Enterobacteriaceae in adult patients with limited treatment options -- SOUTH SAN FRANCISCO, Calif., Oct. [...]
Inovio’s DNA-Encoded Monoclonal Antibody (dMAb™) Platform Moves Ahead with Positive Data, Patents and Grants
17/10/2018
Two new U.S. Patents for Inovio’s dMAb technology were issued Inovio awarded new $2.2 million Gates Foundation grant to support dMAb development and next-generation dMAb delivery clinical device PLYMOUTH MEETING, Pa., [...]
Sirona Biochem Engages Consultant for Japanese Market Penetration
17/10/2018
VANCOUVER, British Columbia , Oct. 17, 2018 (GLOBE NEWSWIRE) -- Sirona Biochem Corp . (TSX-V: SBM) (FSE: ZSB) (Xetra: ZSB) (the “ Company ”) is pleased to announce that it has engaged Mr. Sven Harpering, a Tokyo-based [...]
ORYZON receives approval to start CLEPSIDRA: a Phase IIa clinical trial in Small Cell Lung Cancer with Iadademstat (ORY-1001)
17/10/2018
The study will be done in SCLC patients in combination with Platinum-Etoposide chemotherapy MADRID, Spain and CAMBRIDGE, Mass., Oct. 17, 2018 (GLOBE NEWSWIRE) -- Oryzon Genomics S.A. (ISIN Code: ES0167733015, ORY), (“ [...]

Pages